Literature DB >> 17088478

Identification of CTX-M-type extended-spectrum-beta-lactamase genes using real-time PCR and pyrosequencing.

Thierry Naas1, Cynthia Oxacelay, Patrice Nordmann.   

Abstract

CTX-M extended-spectrum beta-lactamases (ESBLs) are increasingly prevalent worldwide among Escherichia coli bacteria, mostly in community-acquired urinary tract infections. Finding a fast and reliable technique for identification of CTX-M enzymes is becoming a challenge for the microbiology laboratory. A fast real-time PCR amplification technique, using degenerated primers specific for all the bla(CTX-M) alleles, coupled to real-time pyrosequencing was developed. The five CTX-M groups were unambiguously identified by pyrosequencing a 13-bp DNA region. Further sequencing of an additional 16-bp region allowed further division into subgroups. Phylogenetic trees constructed with the entire bla(CTX-M) genes and with both pyrosequenced regions (29 bp) gave similar results, suggesting that this technique, termed the real-time detection and sequencing method, has a powerful discriminatory ability. This high-throughput technique has been evaluated by screening 48 ESBL-producing E. coli isolates recovered from the Bicêtre hospital (France) in 2004. Forty-four of these strains were CTX-M positive by real-time PCR detection and direct pyrosequencing of the PCR products, which identified CTX-M-15 as the main CTX-M-type beta-lactamase. Pulsed-field gel electrophoresis analysis of these strains revealed that several clones, of which one CTX-M-15-positive clone was predominant (60%), were identified both in nosocomial and in community-acquired isolates. The combination of real-time PCR with pyrosequencing represents a powerful tool for epidemiological studies of CTX-M producers. This assay has the potential to be used in a diagnostic laboratory since up to 96 bacterial isolates may be screened in less than 3 h.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17088478      PMCID: PMC1797662          DOI: 10.1128/AAC.00611-06

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  42 in total

1.  Use of the ligase detection reaction-polymerase chain reaction to identify point mutations in extended-spectrum beta-lactamases.

Authors:  C Niederhauser; L Kaempf; I Heinzer
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2000-06       Impact factor: 3.267

2.  Characterization of a chromosomally encoded extended-spectrum class A beta-lactamase from Kluyvera cryocrescens.

Authors:  J W Decousser; L Poirel; P Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2001-12       Impact factor: 5.191

3.  Plasmid-mediated extended-spectrum beta-lactamase (CTX-M-3 like) from India and gene association with insertion sequence ISEcp1.

Authors:  A Karim; L Poirel; S Nagarajan; P Nordmann
Journal:  FEMS Microbiol Lett       Date:  2001-07-24       Impact factor: 2.742

Review 4.  Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat.

Authors:  P A Bradford
Journal:  Clin Microbiol Rev       Date:  2001-10       Impact factor: 26.132

5.  Real-time PCR and melting curve analysis for reliable and rapid detection of SHV extended-spectrum beta-lactamases.

Authors:  C C Randegger; H Hächler
Journal:  Antimicrob Agents Chemother       Date:  2001-06       Impact factor: 5.191

6.  Beta-lactamases of Kluyvera ascorbata, probable progenitors of some plasmid-encoded CTX-M types.

Authors:  Christel Humeniuk; Guillaume Arlet; Valerie Gautier; Patrick Grimont; Roger Labia; Alain Philippon
Journal:  Antimicrob Agents Chemother       Date:  2002-09       Impact factor: 5.191

Review 7.  Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing.

Authors:  F C Tenover; R D Arbeit; R V Goering; P A Mickelsen; B E Murray; D H Persing; B Swaminathan
Journal:  J Clin Microbiol       Date:  1995-09       Impact factor: 5.948

8.  Chromosome-encoded Ambler class A beta-lactamase of Kluyvera georgiana, a probable progenitor of a subgroup of CTX-M extended-spectrum beta-lactamases.

Authors:  Laurent Poirel; Peter Kämpfer; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2002-12       Impact factor: 5.191

9.  CTX-M-type extended-spectrum beta-lactamase that hydrolyzes ceftazidime through a single amino acid substitution in the omega loop.

Authors:  L Poirel; T Naas; I Le Thomas; A Karim; E Bingen; P Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2001-12       Impact factor: 5.191

10.  Integration of a transposon Tn1-encoded inhibitor-resistant beta-lactamase gene, bla(TEM-67) from Proteus mirabilis, into the Escherichia coli chromosome.

Authors:  Thierry Naas; Marie Zerbib; Delphine Girlich; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2003-01       Impact factor: 5.191

View more
  34 in total

1.  Multiple resistance mechanisms acting in unison in an Escherichia coli clinical isolate.

Authors:  Dhriti Mallik; Akash Kumar; Sujoy Kumar Sarkar; Anindya S Ghosh
Journal:  Curr Microbiol       Date:  2013-08-02       Impact factor: 2.188

2.  Typing of SHV extended-spectrum beta-lactamases by pyrosequencing in Klebsiella pneumoniae strains with chromosomal SHV beta-lactamase.

Authors:  Marjo Haanperä; Sofia D Forssten; Pentti Huovinen; Jari Jalava
Journal:  Antimicrob Agents Chemother       Date:  2008-05-05       Impact factor: 5.191

3.  Rapid detection of aac(6')-Ib-cr quinolone resistance gene by pyrosequencing.

Authors:  Thomas Guillard; Véronique Duval; Hélène Moret; Lucien Brasme; Véronique Vernet-Garnier; Christophe de Champs
Journal:  J Clin Microbiol       Date:  2009-11-18       Impact factor: 5.948

4.  Real-time PCR for detection of NDM-1 carbapenemase genes from spiked stool samples.

Authors:  Thierry Naas; Ayla Ergani; Amélie Carrër; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2011-06-20       Impact factor: 5.191

5.  Evaluation of a DNA microarray (Check-MDR CT102) for rapid detection of TEM, SHV, and CTX-M extended-spectrum β-lactamases and of KPC, OXA-48, VIM, IMP, and NDM-1 carbapenemases.

Authors:  Thierry Naas; Gaelle Cuzon; Pierre Bogaerts; Youri Glupczynski; Patrice Nordmann
Journal:  J Clin Microbiol       Date:  2011-02-16       Impact factor: 5.948

6.  Antibiotic resistance and extended spectrum beta-lactamases: Types, epidemiology and treatment.

Authors:  Sibhghatulla Shaikh; Jamale Fatima; Shazi Shakil; Syed Mohd Danish Rizvi; Mohammad Amjad Kamal
Journal:  Saudi J Biol Sci       Date:  2014-08-17       Impact factor: 4.219

7.  Variation-tolerant capture and multiplex detection of nucleic acids: application to detection of microbes.

Authors:  Christina Ohrmalm; Ronnie Eriksson; Magnus Jobs; Magnus Simonson; Maria Strømme; Kåre Bondeson; Björn Herrmann; Asa Melhus; Jonas Blomberg
Journal:  J Clin Microbiol       Date:  2012-07-18       Impact factor: 5.948

8.  Pyrosequencing using the single-nucleotide polymorphism protocol for rapid determination of TEM- and SHV-type extended-spectrum beta-lactamases in clinical isolates and identification of the novel beta-lactamase genes blaSHV-48, blaSHV-105, and blaTEM-155.

Authors:  C Hal Jones; Alexey Ruzin; Margareta Tuckman; Melissa A Visalli; Peter J Petersen; Patricia A Bradford
Journal:  Antimicrob Agents Chemother       Date:  2008-12-15       Impact factor: 5.191

Review 9.  Non-phenotypic tests to detect and characterize antibiotic resistance mechanisms in Enterobacteriaceae.

Authors:  Agnese Lupo; Krisztina M Papp-Wallace; Parham Sendi; Robert A Bonomo; Andrea Endimiani
Journal:  Diagn Microbiol Infect Dis       Date:  2013-10-03       Impact factor: 2.803

10.  Integrated detection of extended-spectrum-beta-lactam resistance by DNA microarray-based genotyping of TEM, SHV, and CTX-M genes.

Authors:  Dirk M Leinberger; Verena Grimm; Maya Rubtsova; Jan Weile; Klaus Schröppel; Thomas A Wichelhaus; Cornelius Knabbe; Rolf D Schmid; Till T Bachmann
Journal:  J Clin Microbiol       Date:  2009-12-09       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.